Affiliated with a Castle Connolly Top Hospital
Who is Dr. Quon, Diagnostic Radiologist in Santa Monica, CA?
Dr. Andrew Quon, MD is a Diagnostic Radiologist, who primarily practices in Santa Monica, CA with 2 additional practice locations. He is board certified. Dr. Quon graduated from University of Texas Southwestern Medical School, Dallas and completed his residency at UCLA School Of Med. Dr. Quon is fluent in English, and is currently seeing new patients. Dr. Quon’s practice accepts Kaiser Permanente, Medicaid, Medicare, Cigna, UnitedHealthcare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Quon’s office at (310) 267-5994.
Where did Dr. Quon go to medical school and complete their residency?
Residency: UCLA School Of Med | Harbor-UCLA Medical Center
Medical School: University of Texas Southwestern Medical School, Dallas
Is Dr. Quon board certified as a Diagnostic Radiologist?
Yes, Dr. Andrew Quon, MD is board certified by the American Board of Nuclear Medicine
What languages does Dr. Quon speak?
Dr. Quon and their clinical team can communicate with patients in the following languages:
English
What conditions does a Diagnostic Radiologist like Dr. Quon typically treat?
As a Diagnostic Radiologist, Dr. Quon diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Quon. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Multiple Site Bone Density and Structure Disorder
- Bone Density Disorder
- Bone Density and Structure Disorder
- Bone Density
- Bone Disease
- Widespread Bone Density Disorder
- Generalized Bone Structure Problem
- Multi-site Bone Disorder
- Bone structure problem
- Low bone density
- Bone mineral density disorder
- Abnormal Bone Density
- Bone Structure Problem
- Bone Disorder
ICD-10 Codes:
- M8589: Other specified disorders of bone density and structure, multiple sites
- M8588: Other specified disorders of bone density and structure, other site
- M8580: Other specified disorders of bone density and structure, unspecified site
Also known as:
- Age-Related Osteoporosis
- Fractures
- Osteoporosis
- Senile Osteoporosis
- Primary Osteoporosis
- Bone Thinning from Aging
ICD-10 Codes:
- M810: Age-related osteoporosis without current pathological fracture
Also known as:
- Prostate Cancer
- Prostate Cancer Treatment (PDQ®)
- Prostatic Carcinoma
- Prostate Gland Cancer
- Malignant Prostate Tumor
ICD-10 Codes:
- C61: Malignant neoplasm of prostate
Also known as:
- Osteoporosis Screening
- Health Screening
- Bone Density Test
- Bone Health Screening
- DEXA Scan
ICD-10 Codes:
- Z13820: Encounter for screening for osteoporosis
Also known as:
- Asymptomatic Menopause
- Menopause
- Menopausal Transition
- Postmenopause
- Change of Life
ICD-10 Codes:
- Z780: Asymptomatic menopausal state
Also known as:
- Bone Density and Structure Disorder
- Bone Density
- Bone Disease
- Bone Structure Problem
- Bone Density Problem
ICD-10 Codes:
- M85852: Other specified disorders of bone density and structure, left thigh
What procedures does a Diagnostic Radiologist like Dr. Quon typically perform?
As a Diagnostic Radiologist, procedures performed by Dr. Andrew Quon may include:
- Abdominal Aortic Aneurysm (AAA) Screening
- Abdominal Imaging
- Abdominal Radiology Consultation
- Angiography
- Arthrography
- Barium Swallow
- Bone Biopsy
- Bone Density Measurement / DXA Scan
Please contact Dr. Quon's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Quon accept my insurance?
Dr. Quon accepts most major insurance plans. Important: Please call our office at (310) 267-5994 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Quon accept in Santa Monica, CA?
Dr. Quon in Santa Monica, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
All Other Third Party
Blue Shield of California
Centene Corporation
CVS Health (formerly Aetna)
Elevance Health Inc. (formerly Anthem)
L.A. Care Health Plan
Medicaid
Medicare
State of California
UnitedHealth Group
View All Insurances
Where is Dr. Quon's office located?
Dr. Andrew Quon's Primary Practice
2020 Santa Monica Blvd Ste 210
Santa Monica, CA 90404
(310) 267-5994
Recognitions
Publications
Impact of positron emission tomography
, 2013
Metabolic Tumor Volume Predicts Disease Progression
, 2013
Metabolic imaging metrics correlate with survival
, 2012
Initial investigation of F-18-F PET
, 2012
Dipeptidyl Peptidase 4 Inhibition Increases Myocardial Glucose Uptake in Nonischemic Cardiomyopathy
, 2012
Postchemoradiotherapy Positron Emission Tomography Predicts Pathologic Response
, 2012
Comparison of MRI and 18F-F PET/CT in patients with patellofemoral pain
, 2012
Positron Emission Tomography for Predicting Pathologic Response After Neoadjuvant Chemoradiotherapy
, 2012
Prognostic PET F-18-FDG Uptake Imaging Features Are Associated with Major Oncogenomic Alterations
, 2012
Non-Small Cell Lung Cancer
, 2012
Patients with patellofemoral pain exhibit elevated bone metabolic activity at the patellofemoral
, 2012
Metabolic Tumor Volume is an Independent Prognostic Factor in Patients Treated Definitively for Non
, 2012
Pattern of 18F-FDG Uptake in the Spil Cord in Patients With Non-Central Nervous System Maligncy
, 2011
POSTRADIATION METABOLIC TUMOR VOLUME PREDICTS OUTCOME IN HEAD-AND-NECK CANCER
, 2011
Tumor Volume as a Potential Imaging-Based Risk
, 2011
F-18-5-fluorouracil dymic positron emission tomography
, 2011
Rosiglitazone Increases Myocardial Glucose Metabolism in Insulin-Resistant Cardiomyopathy
, 2010
Interim positron emission tomography scans in diffuse large B-cell lymphoma
, 2010
Efficacy of F-18-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma
, 2009
Focal fat mimicking multiple hepatic metastases on FDG PET/CT imaging
, 2009
METABOLIC TUMOR VOLUME PREDICTS FOR RECURRENCE AND DEATH IN HEAD-AND-NECK CANCER
, 2009
Simulations of Virtual PET/CT 3-D Bronchoscopy Imaging Using a Physical Porcine Lung-Heart Phantom
, 2009
Detection of Solitary Humeral Metastasis From Pancreatic Adenocarcinoma With F-18 FDG PET/CT
, 2009
Novel Strategy for a Cocktail F-18-Fluoride and F-18-FDG PET
, 2009
Stereotactic Radiotherapy for Unresectable Adenocarcinoma of the Pancreas
, 2009
Positron Emission Tomography/Computed Tomography: The Current Technology and Applications
, 2009
PET/CT Imaging of Gastrointestil Stromal Tumor
, 2008
F-18-FDG PET/CT evaluation of patients with ovarian carcinoma
, 2008
Gemcitabine chemotherapy
, 2008
F-18-FDG-PET/CT evaluation of response to treatment in lymphoma
, 2008
Initial evaluation of F-18-fluorothymidine (FLT) PET/CT scanning for primary pancreatic cancer
, 2008
I-123 MIBG mapping with intraoperative gamma probe for recurrent neuroblastoma
, 2008
FDG PET/CT detection of a gossypiboma in the neck
, 2007
Molecular imaging techniques in body imaging
, 2007
Metabolic tumor burden predicts for disease progression and death in lung cancer
, 2007
Impact of positive positron emission tomography on prediction of freedom from progression after
, 2007
Clinical value of including the head and lower extremities in F-18-FDG PET
, 2007
No apparent alteration of F-18 FDG biodistribution when injected shortly after insulin glargine
, 2007
Advances in metabolic imaging for surgical oncology
, 2007
RT_Image: An open-source tool for investigating PET in radiation oncology
, 2007
Detection of bone metastases: Assessment of integrated FDG PET/CT imaging
, 2007
Impact of integrated PET/CT on variability of target volume delineation in rectal cancer
, 2007
2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography
, 2007
Clinical role of F-18-FDG PET/CT
, 2007
F-18FDG PET/CT evaluation of osseous and soft tissue sarcomas
, 2006
Sonography of the abnormal parathyroid gland.
, 2006
F-18 fluorodeoxyglucose PET/CT
, 2006
Flying through and flying around a PET
, 2006
Merkel cell carcinoma
, 2006
Staging accuracy in mycosis fungoides
, 2006
Diagnosis of aseptic deep venous thrombosis of the upper extremity
, 2006
Performance of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography and integrated PET
, 2005
FDG-PET and beyond: Molecular breast cancer imaging
, 2005
Comparison between 2-deoxy-2-[F-18]fluoro-D-Glucose positron emission tomography
, 2004
Impact of patient weight and emission scan duration on PET
, 2004
Conventiol imaging and 2
, 2004
Relationship between F-18-FDG uptake and breast density in women with normal breast tissue
, 2003
Value of F-18 fluorodeoxyglucose positron emission tomography for predicting the clinical outcome
, 2003
Conventiol imaging and 2
, 2003